Table 2.
Parameters | Before CCRT | After CCRT | P-value |
---|---|---|---|
ALL | |||
Body mass index (kg/m2) | 22.6 (15.1–31.2) | 21.5 (13.3–30.7) | < 0.001 |
Skeletal muscle index (cm2/m2) | 46.0 (27.2–67.7) | 42.2 (20.0–81.4) | < 0.001 |
Fat free mass (kg) | 44.5 (29.1–63.2) | 41.5 (21.3–75.8) | < 0.001 |
Total body fat mass (kg) | 18.9 (11.4–30.4) | 18.2 (11.3–28.6) | 0.207 |
MALE | |||
Body mass index (kg/m2) | 22.6 (15.1–31.2) | 21.4 (13.3–30.7) | < 0.001 |
Skeletal muscle index (cm2/m2) | 46.3 (27.2–67.7) | 42.6 (20.0–81.4) | < 0.001 |
Fat free mass (kg) | 44.9 (29.0–63.2) | 41.6 (21.3–75.8) | < 0.001 |
Total body fat mass (kg) | 18.8 (11.4–30.4) | 18.1 (11.3–28.6) | 0.345 |
FEMALE | |||
Body mass index (kg/m2) | 23.5 (17.0–28.0) | 22.6 (16.6–27.7) | 0.123 |
Skeletal muscle index (cm2/m2) | 38.4 (31.3–48.7) | 33.8 (26.0–38.8) | 0.012 |
Fat free mass (kg) | 33.1 (30.2–38.1) | 28.7 (25.0–32.8) | 0.012 |
Total body fat mass (kg) | 22.7 (14.2–26.3) | 20.5 (14.4–26.1) | 0.263 |
CCRT, concurrent chemo- and radiotherapy.